Jump to content
  • Our Mission Pooling competencies – pushing innovations

    BIOPRO Baden-Württemberg GmbH supports the medical technology, biotechnology and pharmaceutical sectors in the healthcare industry as well as the development of a bioeconomy in Baden-Württemberg.

  • Healthcare industry BW Industry report

    We track the economic performance of companies actively engaged in biotechnology, medical technology and pharmaceutical industry. Our publications provide the latest facts und figures for Baden-Württemberg’s healthcare industry.

  • Bioeconomy BW Towards greater sustainability

    We support regional bioeconomic strategies to promote and strengthen sustainability objectives in Baden-Württemberg. These strategies include regional research and development capacities, analyse approaches for circular economy and aim at the establishment of interfaces to both internal and external partners.

Networking Event

Online
Registration deadline:

BIOPRO Baden-Württemberg GmbH and BioValley France organise their 19th joint Meet & Match event taking place on the 1st of July, 2021. It will be hosted as an online event offering exciting presentations, matchmaking pitches as well as networking sessions.

New on ...

... Healthcare industry BW

Personalised peptide vaccination is expected to improve the treatment of patients with chronic lymphocytic leukaemia. A research team from Tübingen has started a Phase I clinical trial with CLL patients who will undergo ibrutinib treatment. Other leukaemia sufferers as well as cancer patients in general are also expected to benefit in the long term.

... Healthcare industry BW

Pancreatic cancer comes along quietly: unnoticed for a long time, it often triggers excruciating pain as the tumour progresses. This pain is associated with cancer cells invading pancreatic nerves. Dr. Michael Hirth from Mannheim University Hospital has shed some light on the complex communication between cancer cells and nerve cells. His findings could eventually be used for personalised pain therapies.

...Healthcare industry BW

Having long been considered less lucrative for the big pharmaceutical companies, vaccine development is taking off in an unforeseen way in the wake of the COVID-19 pandemic. Financial support is flooding in and all kinds of vaccine development strategies are being deployed. Among the winners in the competition for effective coronavirus vaccines are vaccines based on RNA technology. The development of much-needed vaccines against many other infectious diseases is also expected to benefit from this boom.

...Healthcare Industry BW

Low-grade chronic inflammation caused by components of the innate immune system may increase the risk of developing a variety of diseases in the long term. In their search for the signalling mechanisms underlying these inflammatory processes, Prof. Dr. Olaf Groß' research group at the Freiburg University Medical Centre discovered new active substances with immunostimulatory properties that may open up additional possibilities in cancer immunotherapy.

Website address: https://www.bio-pro.de/en